nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—psoriatic arthritis	0.277	0.344	CbGbCtD
Furosemide—ALB—Auranofin—psoriatic arthritis	0.178	0.221	CbGbCtD
Furosemide—SLC22A11—Methotrexate—psoriatic arthritis	0.0822	0.102	CbGbCtD
Furosemide—ABCC2—Dexamethasone—psoriatic arthritis	0.0567	0.0703	CbGbCtD
Furosemide—ALB—Prednisone—psoriatic arthritis	0.0566	0.0702	CbGbCtD
Furosemide—SLC22A8—Methotrexate—psoriatic arthritis	0.0478	0.0594	CbGbCtD
Furosemide—ABCC2—Methotrexate—psoriatic arthritis	0.0455	0.0565	CbGbCtD
Furosemide—SLC22A6—Methotrexate—psoriatic arthritis	0.0333	0.0414	CbGbCtD
Furosemide—ALB—Methotrexate—psoriatic arthritis	0.0284	0.0352	CbGbCtD
Furosemide—Bladder pain—Methotrexate—psoriatic arthritis	0.000546	0.00281	CcSEcCtD
Furosemide—Purpura—Prednisone—psoriatic arthritis	0.000544	0.0028	CcSEcCtD
Furosemide—Lethargy—Prednisone—psoriatic arthritis	0.000535	0.00275	CcSEcCtD
Furosemide—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000531	0.00273	CcSEcCtD
Furosemide—Muscular weakness—Betamethasone—psoriatic arthritis	0.000531	0.00273	CcSEcCtD
Furosemide—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000506	0.0026	CcSEcCtD
Furosemide—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000504	0.00259	CcSEcCtD
Furosemide—Irritability—Prednisone—psoriatic arthritis	0.000501	0.00258	CcSEcCtD
Furosemide—Photosensitivity—Methotrexate—psoriatic arthritis	0.000499	0.00257	CcSEcCtD
Furosemide—Polyuria—Methotrexate—psoriatic arthritis	0.000499	0.00257	CcSEcCtD
Furosemide—Sweating—Methylprednisolone—psoriatic arthritis	0.000489	0.00252	CcSEcCtD
Furosemide—Visual impairment—Prednisolone—psoriatic arthritis	0.000481	0.00248	CcSEcCtD
Furosemide—Hypokalaemia—Prednisone—psoriatic arthritis	0.000477	0.00246	CcSEcCtD
Furosemide—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00047	0.00242	CcSEcCtD
Furosemide—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00047	0.00242	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000465	0.00239	CcSEcCtD
Furosemide—Muscular weakness—Prednisone—psoriatic arthritis	0.000463	0.00238	CcSEcCtD
Furosemide—Abdominal distension—Prednisone—psoriatic arthritis	0.000456	0.00235	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.000453	0.00233	CcSEcCtD
Furosemide—Lethargy—Methotrexate—psoriatic arthritis	0.000447	0.0023	CcSEcCtD
Furosemide—Arrhythmia—Prednisolone—psoriatic arthritis	0.000446	0.00229	CcSEcCtD
Furosemide—Pancreatitis—Prednisone—psoriatic arthritis	0.000444	0.00229	CcSEcCtD
Furosemide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.000442	0.00227	CcSEcCtD
Furosemide—Erythema—Prednisolone—psoriatic arthritis	0.000435	0.00224	CcSEcCtD
Furosemide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000428	0.0022	CcSEcCtD
Furosemide—Irritability—Methotrexate—psoriatic arthritis	0.000418	0.00215	CcSEcCtD
Furosemide—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000416	0.00214	CcSEcCtD
Furosemide—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000414	0.00213	CcSEcCtD
Furosemide—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00041	0.00211	CcSEcCtD
Furosemide—Vision blurred—Prednisolone—psoriatic arthritis	0.00041	0.00211	CcSEcCtD
Furosemide—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.000409	0.00211	CcSEcCtD
Furosemide—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000409	0.0021	CcSEcCtD
Furosemide—Visual impairment—Dexamethasone—psoriatic arthritis	0.000402	0.00207	CcSEcCtD
Furosemide—Visual impairment—Betamethasone—psoriatic arthritis	0.000402	0.00207	CcSEcCtD
Furosemide—Erythema—Triamcinolone—psoriatic arthritis	0.0004	0.00206	CcSEcCtD
Furosemide—Erythema—Methylprednisolone—psoriatic arthritis	0.000399	0.00205	CcSEcCtD
Furosemide—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000399	0.00205	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.000395	0.00203	CcSEcCtD
Furosemide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.000391	0.00201	CcSEcCtD
Furosemide—Vertigo—Prednisolone—psoriatic arthritis	0.000391	0.00201	CcSEcCtD
Furosemide—Eye disorder—Dexamethasone—psoriatic arthritis	0.000389	0.002	CcSEcCtD
Furosemide—Eye disorder—Betamethasone—psoriatic arthritis	0.000389	0.002	CcSEcCtD
Furosemide—Angiopathy—Dexamethasone—psoriatic arthritis	0.000378	0.00194	CcSEcCtD
Furosemide—Angiopathy—Betamethasone—psoriatic arthritis	0.000378	0.00194	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—psoriatic arthritis	0.000375	0.00193	CcSEcCtD
Furosemide—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000372	0.00191	CcSEcCtD
Furosemide—Arrhythmia—Betamethasone—psoriatic arthritis	0.000372	0.00191	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—psoriatic arthritis	0.000371	0.00191	CcSEcCtD
Furosemide—Erythema—Dexamethasone—psoriatic arthritis	0.000363	0.00187	CcSEcCtD
Furosemide—Erythema—Betamethasone—psoriatic arthritis	0.000363	0.00187	CcSEcCtD
Furosemide—Vertigo—Triamcinolone—psoriatic arthritis	0.000359	0.00185	CcSEcCtD
Furosemide—Vertigo—Methylprednisolone—psoriatic arthritis	0.000358	0.00184	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000355	0.00182	CcSEcCtD
Furosemide—Shock—Prednisolone—psoriatic arthritis	0.000349	0.0018	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000346	0.00178	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000343	0.00176	CcSEcCtD
Furosemide—Eye disorder—Prednisone—psoriatic arthritis	0.000339	0.00174	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—psoriatic arthritis	0.000338	0.00174	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000337	0.00173	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.000335	0.00172	CcSEcCtD
Furosemide—Dry mouth—Triamcinolone—psoriatic arthritis	0.000333	0.00171	CcSEcCtD
Furosemide—Renal failure—Methotrexate—psoriatic arthritis	0.000332	0.00171	CcSEcCtD
Furosemide—Angiopathy—Prednisone—psoriatic arthritis	0.000329	0.00169	CcSEcCtD
Furosemide—Confusional state—Methylprednisolone—psoriatic arthritis	0.000328	0.00169	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—psoriatic arthritis	0.000328	0.00169	CcSEcCtD
Furosemide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000326	0.00168	CcSEcCtD
Furosemide—Vertigo—Dexamethasone—psoriatic arthritis	0.000326	0.00168	CcSEcCtD
Furosemide—Vertigo—Betamethasone—psoriatic arthritis	0.000326	0.00168	CcSEcCtD
Furosemide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000326	0.00167	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—psoriatic arthritis	0.000324	0.00167	CcSEcCtD
Furosemide—Sweating—Methotrexate—psoriatic arthritis	0.000324	0.00167	CcSEcCtD
Furosemide—Shock—Triamcinolone—psoriatic arthritis	0.000321	0.00165	CcSEcCtD
Furosemide—Shock—Methylprednisolone—psoriatic arthritis	0.00032	0.00165	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000319	0.00164	CcSEcCtD
Furosemide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000319	0.00164	CcSEcCtD
Furosemide—Paraesthesia—Prednisolone—psoriatic arthritis	0.000319	0.00164	CcSEcCtD
Furosemide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000316	0.00163	CcSEcCtD
Furosemide—Erythema—Prednisone—psoriatic arthritis	0.000316	0.00162	CcSEcCtD
Furosemide—Malnutrition—Prednisone—psoriatic arthritis	0.000316	0.00162	CcSEcCtD
Furosemide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000315	0.00162	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000315	0.00162	CcSEcCtD
Furosemide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000315	0.00162	CcSEcCtD
Furosemide—Hypotension—Methylprednisolone—psoriatic arthritis	0.000304	0.00156	CcSEcCtD
Furosemide—Pain—Prednisolone—psoriatic arthritis	0.000303	0.00156	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000299	0.00154	CcSEcCtD
Furosemide—Vision blurred—Prednisone—psoriatic arthritis	0.000298	0.00153	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—psoriatic arthritis	0.000297	0.00153	CcSEcCtD
Furosemide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000296	0.00152	CcSEcCtD
Furosemide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000296	0.00152	CcSEcCtD
Furosemide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000293	0.00151	CcSEcCtD
Furosemide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Furosemide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Furosemide—Anaemia—Prednisone—psoriatic arthritis	0.000292	0.0015	CcSEcCtD
Furosemide—Shock—Betamethasone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Furosemide—Shock—Dexamethasone—psoriatic arthritis	0.000291	0.0015	CcSEcCtD
Furosemide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Furosemide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Furosemide—Agitation—Prednisone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Furosemide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Furosemide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00029	0.00149	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000287	0.00147	CcSEcCtD
Furosemide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000286	0.00147	CcSEcCtD
Furosemide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000286	0.00147	CcSEcCtD
Furosemide—Vertigo—Prednisone—psoriatic arthritis	0.000284	0.00146	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—psoriatic arthritis	0.000283	0.00146	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—psoriatic arthritis	0.000283	0.00145	CcSEcCtD
Furosemide—Anorexia—Dexamethasone—psoriatic arthritis	0.000282	0.00145	CcSEcCtD
Furosemide—Anorexia—Betamethasone—psoriatic arthritis	0.000282	0.00145	CcSEcCtD
Furosemide—Urticaria—Prednisolone—psoriatic arthritis	0.000282	0.00145	CcSEcCtD
Furosemide—Fatigue—Triamcinolone—psoriatic arthritis	0.000281	0.00145	CcSEcCtD
Furosemide—Fatigue—Methylprednisolone—psoriatic arthritis	0.000281	0.00144	CcSEcCtD
Furosemide—Pain—Triamcinolone—psoriatic arthritis	0.000279	0.00144	CcSEcCtD
Furosemide—Hypotension—Dexamethasone—psoriatic arthritis	0.000277	0.00142	CcSEcCtD
Furosemide—Hypotension—Betamethasone—psoriatic arthritis	0.000277	0.00142	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—psoriatic arthritis	0.000275	0.00142	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—psoriatic arthritis	0.000274	0.00141	CcSEcCtD
Furosemide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000269	0.00138	CcSEcCtD
Furosemide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000268	0.00138	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000267	0.00137	CcSEcCtD
Furosemide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Furosemide—Paraesthesia—Betamethasone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Furosemide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000266	0.00137	CcSEcCtD
Furosemide—Erythema—Methotrexate—psoriatic arthritis	0.000264	0.00136	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—psoriatic arthritis	0.000264	0.00136	CcSEcCtD
Furosemide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000261	0.00134	CcSEcCtD
Furosemide—Urticaria—Triamcinolone—psoriatic arthritis	0.000259	0.00133	CcSEcCtD
Furosemide—Urticaria—Methylprednisolone—psoriatic arthritis	0.000259	0.00133	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—psoriatic arthritis	0.000259	0.00133	CcSEcCtD
Furosemide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000258	0.00133	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000258	0.00133	CcSEcCtD
Furosemide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000257	0.00132	CcSEcCtD
Furosemide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000257	0.00132	CcSEcCtD
Furosemide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000257	0.00132	CcSEcCtD
Furosemide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000256	0.00131	CcSEcCtD
Furosemide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000256	0.00131	CcSEcCtD
Furosemide—Fatigue—Dexamethasone—psoriatic arthritis	0.000255	0.00131	CcSEcCtD
Furosemide—Fatigue—Betamethasone—psoriatic arthritis	0.000255	0.00131	CcSEcCtD
Furosemide—Shock—Prednisone—psoriatic arthritis	0.000254	0.0013	CcSEcCtD
Furosemide—Pain—Betamethasone—psoriatic arthritis	0.000253	0.0013	CcSEcCtD
Furosemide—Pain—Dexamethasone—psoriatic arthritis	0.000253	0.0013	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—psoriatic arthritis	0.000253	0.0013	CcSEcCtD
Furosemide—Skin disorder—Prednisone—psoriatic arthritis	0.00025	0.00129	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000249	0.00128	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—psoriatic arthritis	0.000249	0.00128	CcSEcCtD
Furosemide—Anorexia—Prednisone—psoriatic arthritis	0.000246	0.00126	CcSEcCtD
Furosemide—Anaemia—Methotrexate—psoriatic arthritis	0.000244	0.00126	CcSEcCtD
Furosemide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000244	0.00125	CcSEcCtD
Furosemide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000244	0.00125	CcSEcCtD
Furosemide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000242	0.00125	CcSEcCtD
Furosemide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000242	0.00125	CcSEcCtD
Furosemide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00024	0.00124	CcSEcCtD
Furosemide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00024	0.00123	CcSEcCtD
Furosemide—Vertigo—Methotrexate—psoriatic arthritis	0.000237	0.00122	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—psoriatic arthritis	0.000236	0.00122	CcSEcCtD
Furosemide—Urticaria—Betamethasone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Furosemide—Urticaria—Dexamethasone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Furosemide—Dizziness—Prednisolone—psoriatic arthritis	0.000235	0.00121	CcSEcCtD
Furosemide—Asthenia—Triamcinolone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Body temperature increased—Betamethasone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000234	0.0012	CcSEcCtD
Furosemide—Paraesthesia—Prednisone—psoriatic arthritis	0.000231	0.00119	CcSEcCtD
Furosemide—Pruritus—Triamcinolone—psoriatic arthritis	0.000231	0.00119	CcSEcCtD
Furosemide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00023	0.00118	CcSEcCtD
Furosemide—Decreased appetite—Prednisone—psoriatic arthritis	0.000224	0.00115	CcSEcCtD
Furosemide—Rash—Prednisolone—psoriatic arthritis	0.000224	0.00115	CcSEcCtD
Furosemide—Dermatitis—Prednisolone—psoriatic arthritis	0.000223	0.00115	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000223	0.00115	CcSEcCtD
Furosemide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000223	0.00115	CcSEcCtD
Furosemide—Fatigue—Prednisone—psoriatic arthritis	0.000222	0.00114	CcSEcCtD
Furosemide—Headache—Prednisolone—psoriatic arthritis	0.000222	0.00114	CcSEcCtD
Furosemide—Constipation—Prednisone—psoriatic arthritis	0.00022	0.00113	CcSEcCtD
Furosemide—Confusional state—Methotrexate—psoriatic arthritis	0.000217	0.00112	CcSEcCtD
Furosemide—Dizziness—Triamcinolone—psoriatic arthritis	0.000216	0.00111	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Furosemide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000215	0.00111	CcSEcCtD
Furosemide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000212	0.00109	CcSEcCtD
Furosemide—Asthenia—Betamethasone—psoriatic arthritis	0.000212	0.00109	CcSEcCtD
Furosemide—Asthenia—Dexamethasone—psoriatic arthritis	0.000212	0.00109	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000211	0.00109	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000211	0.00109	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000211	0.00108	CcSEcCtD
Furosemide—Nausea—Prednisolone—psoriatic arthritis	0.000211	0.00108	CcSEcCtD
Furosemide—Pruritus—Dexamethasone—psoriatic arthritis	0.000209	0.00108	CcSEcCtD
Furosemide—Pruritus—Betamethasone—psoriatic arthritis	0.000209	0.00108	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—psoriatic arthritis	0.000209	0.00108	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000208	0.00107	CcSEcCtD
Furosemide—Vomiting—Triamcinolone—psoriatic arthritis	0.000207	0.00107	CcSEcCtD
Furosemide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000207	0.00106	CcSEcCtD
Furosemide—Rash—Triamcinolone—psoriatic arthritis	0.000206	0.00106	CcSEcCtD
Furosemide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000206	0.00106	CcSEcCtD
Furosemide—Anorexia—Methotrexate—psoriatic arthritis	0.000205	0.00106	CcSEcCtD
Furosemide—Rash—Methylprednisolone—psoriatic arthritis	0.000205	0.00106	CcSEcCtD
Furosemide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000205	0.00105	CcSEcCtD
Furosemide—Urticaria—Prednisone—psoriatic arthritis	0.000205	0.00105	CcSEcCtD
Furosemide—Headache—Triamcinolone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Furosemide—Headache—Methylprednisolone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—psoriatic arthritis	0.000204	0.00105	CcSEcCtD
Furosemide—Diarrhoea—Betamethasone—psoriatic arthritis	0.000203	0.00104	CcSEcCtD
Furosemide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000203	0.00104	CcSEcCtD
Furosemide—Hypotension—Methotrexate—psoriatic arthritis	0.000201	0.00104	CcSEcCtD
Furosemide—Dizziness—Betamethasone—psoriatic arthritis	0.000196	0.00101	CcSEcCtD
Furosemide—Dizziness—Dexamethasone—psoriatic arthritis	0.000196	0.00101	CcSEcCtD
Furosemide—Nausea—Triamcinolone—psoriatic arthritis	0.000194	0.000997	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000193	0.000995	CcSEcCtD
Furosemide—Nausea—Methylprednisolone—psoriatic arthritis	0.000193	0.000995	CcSEcCtD
Furosemide—Somnolence—Methotrexate—psoriatic arthritis	0.000192	0.000985	CcSEcCtD
Furosemide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00019	0.000977	CcSEcCtD
Furosemide—Vomiting—Betamethasone—psoriatic arthritis	0.000188	0.000968	CcSEcCtD
Furosemide—Vomiting—Dexamethasone—psoriatic arthritis	0.000188	0.000968	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000187	0.000963	CcSEcCtD
Furosemide—Rash—Dexamethasone—psoriatic arthritis	0.000187	0.00096	CcSEcCtD
Furosemide—Rash—Betamethasone—psoriatic arthritis	0.000187	0.00096	CcSEcCtD
Furosemide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000186	0.000959	CcSEcCtD
Furosemide—Dermatitis—Betamethasone—psoriatic arthritis	0.000186	0.000959	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000186	0.000957	CcSEcCtD
Furosemide—Fatigue—Methotrexate—psoriatic arthritis	0.000186	0.000955	CcSEcCtD
Furosemide—Headache—Betamethasone—psoriatic arthritis	0.000185	0.000954	CcSEcCtD
Furosemide—Headache—Dexamethasone—psoriatic arthritis	0.000185	0.000954	CcSEcCtD
Furosemide—Asthenia—Prednisone—psoriatic arthritis	0.000185	0.000951	CcSEcCtD
Furosemide—Pain—Methotrexate—psoriatic arthritis	0.000184	0.000948	CcSEcCtD
Furosemide—Pruritus—Prednisone—psoriatic arthritis	0.000182	0.000938	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000178	0.000913	CcSEcCtD
Furosemide—Diarrhoea—Prednisone—psoriatic arthritis	0.000176	0.000907	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000176	0.000906	CcSEcCtD
Furosemide—Nausea—Betamethasone—psoriatic arthritis	0.000176	0.000904	CcSEcCtD
Furosemide—Nausea—Dexamethasone—psoriatic arthritis	0.000176	0.000904	CcSEcCtD
Furosemide—Urticaria—Methotrexate—psoriatic arthritis	0.000171	0.00088	CcSEcCtD
Furosemide—Dizziness—Prednisone—psoriatic arthritis	0.00017	0.000877	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00017	0.000876	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00017	0.000876	CcSEcCtD
Furosemide—Vomiting—Prednisone—psoriatic arthritis	0.000164	0.000843	CcSEcCtD
Furosemide—Rash—Prednisone—psoriatic arthritis	0.000163	0.000836	CcSEcCtD
Furosemide—Dermatitis—Prednisone—psoriatic arthritis	0.000162	0.000835	CcSEcCtD
Furosemide—Headache—Prednisone—psoriatic arthritis	0.000161	0.000831	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000159	0.000816	CcSEcCtD
Furosemide—Asthenia—Methotrexate—psoriatic arthritis	0.000155	0.000795	CcSEcCtD
Furosemide—Nausea—Prednisone—psoriatic arthritis	0.000153	0.000788	CcSEcCtD
Furosemide—Pruritus—Methotrexate—psoriatic arthritis	0.000152	0.000784	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000147	0.000758	CcSEcCtD
Furosemide—Dizziness—Methotrexate—psoriatic arthritis	0.000142	0.000733	CcSEcCtD
Furosemide—Vomiting—Methotrexate—psoriatic arthritis	0.000137	0.000705	CcSEcCtD
Furosemide—Rash—Methotrexate—psoriatic arthritis	0.000136	0.000699	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—psoriatic arthritis	0.000136	0.000698	CcSEcCtD
Furosemide—Headache—Methotrexate—psoriatic arthritis	0.000135	0.000694	CcSEcCtD
Furosemide—Nausea—Methotrexate—psoriatic arthritis	0.000128	0.000658	CcSEcCtD
